⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5633364 | 0.85 | — | — | |
| SCHEMBL7298166 | 0.82 | — | — | |
| SCHEMBL3594415 | 0.82 | — | — | |
| SCHEMBL1162626 | 0.81 | — | — | |
| SCHEMBL10584390 | 0.80 | — | — | |
| SCHEMBL14343367 | 0.73 | P4HB (0.32) | — | |
| SCHEMBL21409026 | 0.73 | — | — | |
| SCHEMBL2497821 | 0.73 | — | — | |
| SCHEMBL2224543 | 0.73 | — | — | |
| SCHEMBL376992 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250026734-A1 | ANTI-SARS-COV-2 DRUG | ONCOLYS BIOPHARMA, INC. (JP) | 2025-01-23 | — | — | US | disclosed |
| WO-2024237331-A1 | CHOLINE SALT OF PHENANTHRIDINONE DERIVATIVE | オンコリスバイオファーマ株式会社 | 2024-11-21 | — | — | WO | disclosed |
| EP-4434969-A1 | ANTI-SARS-COV-2 DRUG | Oncolys BioPharma, Inc. (JP) | 2024-09-25 | — | — | EP | disclosed |
| WO-2023085432-A1 | ANTI-SARS-COV-2 DRUG | オンコリスバイオファーマ株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-20100240638-A1 | Organic Compounds and their uses | NOVARTIS AG (CH) | 2010-09-23 | — | — | US | disclosed |